Exogenous Surfactant in Very Preterm Neonates Presenting With Severe Respiratory Distress in Prevention of Bronchopulmonary Dysplasia

Trial Profile

Exogenous Surfactant in Very Preterm Neonates Presenting With Severe Respiratory Distress in Prevention of Bronchopulmonary Dysplasia

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 29 Feb 2016

At a glance

  • Drugs Poractant alfa (Primary)
  • Indications Bronchopulmonary dysplasia
  • Focus Therapeutic Use
  • Acronyms CURDYS
  • Most Recent Events

    • 29 Feb 2016 Results published in the JAMA Pediatrics
    • 13 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top